The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's Enhertu in combination with Roche ...
Matan Companies is proud to announce that its premier 44-acre life science and industrial campus fronting I-270 in ...
Khaleej Times on MSN
US FDA approves AstraZeneca, Daiichi's breast cancer drug as first-line treatment
The US Food and Drug Administration has approved Daiichi Sankyo's therapy in combination with Roche's drug for the first-line ...
Patients with chronic spontaneous urticaria experienced relief in itch and hives by day 3 with povorcitinib, according to ...
The appeal of these diverse careers often lies in the different types of impact they enable. A PhD can teach more than ...
Fresh off a $153 million series E round, Arthrosi Therapeutics is skipping an IPO route and is instead being bought up for a ...
Viewed through a financial and legal lens, the Kenya-US framework represents a case of incomplete technology transfer.
The Hechinger Report on MSN
The US wants more apprenticeships. The UK figured out how to make them coveted roles
England has embraced degree apprenticeship as a solution to a wide range of challenges, including high youth unemployment, spiraling student debt and rapid technological change. The programs have been ...
Among seven new medicines recommended for approval by the EMA's human medicine advisory committee at its latest meeting is ...
Montgomery County Public Schools’ deal brings Matan’s life sciences and industrial property to full occupancy.
We found that one-third of pharmaceutical companies proactively released the launch price of their medications between 2022 and 2024, and another third released them reactively. Smaller public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results